Publisher's Synopsis
Reviews the current understanding of the neuroinflammatory mediators and cells involved in neurodegenerative diseases. Begins with current views of how they are implicated in neuronal loss and the mechanisms of cell death, then critically examines current research on designing specific pharmacologic